N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: Time-to-kill, stability, interaction with maleamic acids

Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis

Michael B. Edmond, Stephanie E Wallace, Donna K. McClish et al. · Clinical Infectious Diseases · 1999 · 1.4K citations

Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990

C. M. B. Sague, William R. Jarvis · The Journal of Infectious Diseases · 1993 · 1.1K citations

Antifungal Agent, Secular Trend, Secular Trends +12

Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

Michael E. Klepser, Erika J. Ernst, Russell E. Lewis et al. · Antimicrobial Agents and Chemotherapy · 1998 · 328 citations · Full text

Antifungal Agent, Antimicrobial Susceptibility, Antifungal Agents +12

In Vitro Synergy of Caspofungin and Amphotericin B against <i>Aspergillus</i> and <i>Fusarium</i> spp

Sevtap Arıkan, Mario Lozano‐Chiu, Victor L. Paetznick et al. · Antimicrobial Agents and Chemotherapy · 2002 · 279 citations · Full text

Antifungal Agent, Health Sciences, Vitro Synergy +14

Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans

Michael E. Klepser, Erika J. Wolfe, Ronald N. Jones et al. · Antimicrobial Agents and Chemotherapy · 1997 · 245 citations · Full text

Fungistatic Activity, Time-kill Curves, Antifungal Agent +14